<?xml version="1.0" encoding="UTF-8"?>
<ref id="B98">
 <label>98.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Hou</surname>
    <given-names>AW</given-names>
   </name>
   <name>
    <surname>Morrill</surname>
    <given-names>AM</given-names>
   </name>
  </person-group>. 
  <article-title>Obiltoxaximab: adding to the treatment arsenal for 
   <italic>Bacillus Anthracis</italic> infection
  </article-title>. 
  <source>Ann Pharmacother</source>. (
  <year>2017</year>) 
  <volume>51</volume>:
  <fpage>908</fpage>â€“
  <lpage>13</lpage>. 
  <pub-id pub-id-type="doi">10.1177/1060028017713029</pub-id>
  <?supplied-pmid 28573869?>
  <pub-id pub-id-type="pmid">28573869</pub-id>
 </mixed-citation>
</ref>
